Rising Pneumococcal Antibiotic Resistance in the Post–13-Valent Pneumococcal Conjugate Vaccine Era in Pediatric Isolates From a Primary Care Setting | Zendy

Ravinder Kaur | Zendy; Minh Pham | Zendy; Karl O. A. Yu | Zendy; Michael E. Pichichero | Zendy

Open Access

Rising Pneumococcal Antibiotic Resistance in the Post–13-Valent Pneumococcal Conjugate Vaccine Era in Pediatric Isolates From a Primary Care Setting

Author(s) -

Ravinder Kaur,

Minh Pham,

Karl O. A. Yu,

Michael E. Pichichero

Publication year - 2020

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciaa157

Subject(s) - medicine , pneumococcal conjugate vaccine , antibiotics , pneumococcal infections , streptococcus pneumoniae , antibiotic resistance , primary care , pneumococcal vaccine , pediatrics , microbiology and biotechnology , intensive care medicine , family medicine , biology

Antibiotic-resistant Streptococcus pneumoniae strains may cause infections that fail to respond to antimicrobial therapy. Results reported from hospitalized patients with invasive, bacteremic infections may not be the same as those observed in a primary care setting where young children receive care for noninvasive infections. Young children experience the highest burden of pneumococcal disease. The aim of this study was to determine the antibiotic susceptibility of S. pneumoniae strains isolated from children in a primary care setting in the post-13-valent pneumococcal conjugate vaccine (PCV13) era.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research